AFFX Affymetrix, Inc.

Affymetrix Inc. (Nasdaq:AFFX): WHAT: Attend a public symposium focusing on personalized medicine. Distinguished experts from academia, government and industry will be discussing the opportunities and challenges facing scientists, healthcare providers, policy makers and society as a whole. � To view the complete agenda, please visit: http://www.cgm.northwestern.edu/geneticage.htm � WHO: The Genetic Age Symposium is a free event and webcast that is open to the public. � WHEN: Monday, December 4, 2006, 8:00 a.m. - 1:00 p.m. CST � WHERE: Hughes Auditorium Robert H. Lurie Medical Research Center 303 East Superior Street Chicago, IL 60611 For directions/parking/public transportation, please select the Chicago Campus map: http://www.northwestern.edu/visiting/maps/ For updates on this symposium and webcast information, please visit: http://www.cgm.northwestern.edu For any questions regarding the Genetic Age Symposium, please contact via email: genetic-medicine@northwestern.edu or via telephone: (312) 503-5600 About Affymetrix Affymetrix Inc. (Nasdaq:AFFX) scientists invented the world�s first high-density microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip� technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world�s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been installed around the world and more than 7,000 peer-reviewed papers have been published using the technology. Affymetrix� patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health. Affymetrix is headquartered in Santa Clara, Calif., with manufacturing facilities in Sacramento, Calif., and Bedford, Mass. The company maintains important sales and marketing operations in Europe and Asia, and has about 1,100 employees worldwide. For more information about Affymetrix, please visit the company�s website at www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo and GeneChip� are registered trademarks owned or used by Affymetrix Inc. Affymetrix Inc. (Nasdaq:AFFX): -0- *T WHAT: Attend a public symposium focusing on personalized medicine. Distinguished experts from academia, government and industry will be discussing the opportunities and challenges facing scientists, healthcare providers, policy makers and society as a whole. To view the complete agenda, please visit: http://www.cgm.northwestern.edu/geneticage.htm WHO: The Genetic Age Symposium is a free event and webcast that is open to the public. WHEN: Monday, December 4, 2006, 8:00 a.m. - 1:00 p.m. CST WHERE: Hughes Auditorium Robert H. Lurie Medical Research Center 303 East Superior Street Chicago, IL 60611 *T For directions/parking/public transportation, please select the Chicago Campus map: http://www.northwestern.edu/visiting/maps/ For updates on this symposium and webcast information, please visit: http://www.cgm.northwestern.edu For any questions regarding the Genetic Age Symposium, please contact via email: genetic-medicine@northwestern.edu or via telephone: (312) 503-5600 About Affymetrix Affymetrix Inc. (Nasdaq:AFFX) scientists invented the world's first high-density microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been installed around the world and more than 7,000 peer-reviewed papers have been published using the technology. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyzing the relationship between genetics and health. Affymetrix is headquartered in Santa Clara, Calif., with manufacturing facilities in Sacramento, Calif., and Bedford, Mass. The company maintains important sales and marketing operations in Europe and Asia, and has about 1,100 employees worldwide. For more information about Affymetrix, please visit the company's website at www.affymetrix.com. NOTE: Affymetrix, the Affymetrix logo and GeneChip(R) are registered trademarks owned or used by Affymetrix Inc.